NanOlogy in the News
NanOlogy in the News
-
OncLive: LSAM-DTX Effective and Safe in NMIBC Using Direct, Multifaceted Approach
September 16, 2021 by NanOlogy
-
Target Oncology: Direct and Multifaceted LSAM-DTX Treatment May Be Safe and Effective in NMIBC
September 16, 2021 by NanOlogy
-
JACS: Surgery is a viable treatment for pancreatic cancer patients especially after chemotherapy
March 26, 2021 by NanOlogy
-
Current Urology Reports: Current Clinical Trials in Non-muscle-Invasive Bladder Cancer: Heightened Need in an Era of Chronic BCG Shortage
January 9, 2020 by NanOlogy
-
Drug Development Technology: NanOlogy Starts Enrollment in NanoDoce’s Phase I/II Trial
May 7, 2019 by NanOlogy
-
NanOlogy Named to BioSpace Top 20 Life Science Startups to Watch in 2019
January 11, 2019 by NanOlogy
-
Wuxi AppTec: Small Molecule Chemotherapy May Play a Big Role in Cancer Immunotherapy
November 6, 2018 by NanOlogy
-
Drug Development: Targeted Delivery of Submicron Particle Cancer Chemotherapy: Helping Shift the Immunotherapy Paradigm
August 29, 2018 by NanOlogy
-
Drug Delivery: NanOlogy Touts Preclinical Data for Inhaled NanoPac Cancer Drug
May 30, 2018 by NanOlogy
-
Boston Business Journal: NanOlogy Completes Dose Escalation Portion of Phase 2 Clinical Trial of NanoPac for Treatment of Prostate Cancer
May 3, 2018 by NanOlogy
-
BioCentury: Tiny Taxanes – How Nanology’s Particle Production Technology Created Submicron Chemotherapy
April 9, 2018 by NanOlogy
-
Drug Delivery: NanOlogy looks to transform chemotherapy with localized delivery platform
March 5, 2018 by NanOlogy
-
Drug Development: NanOlogy Submicron Particle Platform Transforms Systemic Chemotherapy Into Local Delivery
February 28, 2018 by NanOlogy
-
DermWire: NanOlogy Enrolls First Patient in Clinical Trial for Cutaneous Metastases
February 14, 2018 by NanOlogy
-
Houston Business Journal: NanOlogy to Update Clinical Program at BIO CEO Conference
February 5, 2018 by NanOlogy
-
PharmaVOICE: Next-Generation Nanomedicines
January 3, 2018 by NanOlogy
-
Drug Delivery Business: NanOlogy takes nanoparticle tech into Phase II trials
December 19, 2017 by NanOlogy
-
Clinical Leader: Trial Aims To Kill Cancer Without Chemotherapy Side Effects
November 20, 2017 by NanOlogy
-
DDNEWS: New Cancer Answer
November 13, 2017 by NanOlogy
-
Ovarian Cancer News: First Patient Enrolled in NanoPac Trial Evaluating New Anti-Cancer Treatment Delivery
October 16, 2017 by NanOlogy
